Design and rationale of the MODULAR ATP global clinical trial: A novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter-defibrillator

BACKGROUND: The subcutaneous implantable cardioverter-defibrillator (S-ICD) has demonstrated safety and efficacy for the treatment of malignant ventricular arrhythmias. However, a limitation of the S-ICD lies in the inability to either pace-terminate ventricular tachycardia or provide prolonged brad...

Descripción completa

Detalles Bibliográficos
Autores principales: Lloyd, Michael S., Brisben, Amy J., Reddy, Vivek Y., Blomström-Lundqvist, Carina, Boersma, Lucas V.A., Bongiorni, Maria Grazia, Burke, Martin C., Cantillon, Daniel J., Doshi, Rahul, Friedman, Paul A., Gras, Daniel, Kutalek, Steven P., Neuzil, Petr, Roberts, Paul R., Wright, David J., Appl, Ursula, West, Julie, Carter, Nathan, Stein, Kenneth M., Mont, Lluis, Knops, Reinoud E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Design Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373150/
https://www.ncbi.nlm.nih.gov/pubmed/37520021
http://dx.doi.org/10.1016/j.hroo.2023.05.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373150/
https://www.ncbi.nlm.nih.gov/pubmed/37520021
http://dx.doi.org/10.1016/j.hroo.2023.05.004

Ejemplares similares